DUNNE MICHAEL W. (Chief Scientific Officer) purchased 6.8% of their position (15K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market purchase worth $10.9K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/12/2025ACC: 0000950170-25-106908
Officer· Chief Scientific Officer
Since Aug 2018
+15K
Net shares
Net buyer
$10.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+15K
Price / share
$0.72
Trade value
$10.85K
% of position
6.8%
8/8/2025
220K→235K
Total
Net shares
+15K
Net value
$10.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/8/2025 | P · Purchase | +15K | $0.72 | $10.85K | 6.8% | 220K | 235K |
| Total | +15K | $10.85K | ||||||
Derivative Transactions0
No derivative transactions reported